| Editor's Choice: TAVR | Transcaval TAVR was linked to a much lower stroke rate and fewer bleeding complications. Transcaval TAVR was linked to a much lower stroke rate and fewer bleeding complications. | | |
| “We believe this case is potentially groundbreaking," one interventional cardiologist said. “We believe this case is potentially groundbreaking," one interventional cardiologist said. | | |
| The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world. The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world. | | |
| Patients with higher levels of extravalvular cardiac damage prior to TAVR or SAVR face a higher risk of dying within two years, according to new findings presented at EuroPCR 2022 in Paris. Patients with higher levels of extravalvular cardiac damage prior to TAVR or SAVR face a higher risk of dying within two years, according to new findings presented at EuroPCR 2022 in Paris. | | |
| CT-FFR, which recently got a boost from the 2021 AHA/ACC chest pain guidelines, could play a key role for clinicians hoping to screen TAVR patients for coronary heart disease. CT-FFR, which recently got a boost from the 2021 AHA/ACC chest pain guidelines, could play a key role for clinicians hoping to screen TAVR patients for coronary heart disease. | | |
| The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems. The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems. | | |
| All-cause mortality after one year was 4.6% for the TAVR group and 6.6% for the SAVR group All-cause mortality after one year was 4.6% for the TAVR group and 6.6% for the SAVR group | | |
| MAVD patients did face a higher risk of requiring a permanent pacemaker, researchers noted, though the reason for this trend remains unclear. MAVD patients did face a higher risk of requiring a permanent pacemaker, researchers noted, though the reason for this trend remains unclear. | | |
| Researchers tracked data from more than 2,000 TAVR patients, focusing on cardiovascular mortality and hospitalizations for heart failure. Researchers tracked data from more than 2,000 TAVR patients, focusing on cardiovascular mortality and hospitalizations for heart failure. | | |
| |
|
| ![]() | |
|
